Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained turnaround is close for PFE stock.

The company also announced a $2.4 billion stock repurchase plan partially funded by the sale ... power generating facilities, and provides de-carbonization solutions and services, such as hydrogen ...

Pfizer (PFE-N) on Tuesday forecast 2025 profits roughly ... will be introduced for seniors who have the prescription drug plan next year. On Tuesday, Pfizer said it does not expect the Trump ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% ...